Last updated on April 2018

Project I Test: Implementing HIV Testing in Opioid Treatment Programs


Brief description of study

This study will test two active evidence-based "practice coaching" (PC) interventions to improve opioid treatment programs' (OTPs') provision and sustained implementation of on-site

  1. HIV testing and linkage to care and 2) joint HIV/Hepatitis C virus (HCV) testing and linkage to care among patients seeking/receiving substance use disorder treatment.

Aims are:

Aim 1: To evaluate the effectiveness of the PC interventions on improving patient uptake of HIV testing in OTPs including the incremental impact of the HIV/HCV intervention on HIV testing.

Aim 2: To examine, using mixed-methods, the impact of the PC interventions on the initiation and sustained provision of HIV testing and timely linkage to care.

Aim 3: To evaluate the health outcomes, health care utilization, and cost-effectiveness of the PC interventions compared incrementally to one another and to the control condition.

Primary Hypothesis:

  1. The two PC interventions will result in significantly higher rates of HIV testing than the information control condition in the first period after intervention (initial uptake--Primary) and after 12 months of follow-up after initial uptake (sustained implementation--Secondary).
  2. The HIV/HCV testing PC intervention will have a significantly higher rate of HIV testing in the first period after intervention and after 12 months of follow-up compared with the HIV testing only PC intervention (Secondary).

Detailed Study Description

Using the most recent National Survey of Substance Abuse Treatment Services (N-SSATS) data available from the Substance Abuse and Mental Health Services Administration (SAMHSA) as the sampling frame, 51 sites will be randomly selected to participate in the study. Site randomization to condition will occur in waves. Selected sites will be invited to participate in the study and randomly assigned to one of the three intervention conditions (17 sites per condition) -- information control, HIV PC, and HIV/HCV PC. The control condition will be an HIV testing informational product consisting of the official NIDA/SAMHSA Blending Initiative product, "HIV Rapid Testing in Substance Abuse Treatment Programs," ARTAS intervention information and Pre-Exposure Prophylaxis (PrEP) information that will be provided to OTPs to educate and motivate them about the importance of offering on-site HIV testing and linkage to care. In the active PC conditions, change agents and key OTP staff will be provided training and support to facilitate the implementation of innovation and sustain resulting improvements in testing.

De-identified aggregate client data on HIV and HCV testing will be collected from the sites for a period 6 months prior to intervention, the 6 months during the intervention, 6 months after the intervention, and 12 months after the intervention. Qualitative and quantitative site-level data will also be collected immediately preceding the intervention and again approximately 4 months after intervention.

Clinical Study Identifier: NCT03135886

Contact Investigators or Research Sites near you

Start Over

Lisa Metsch, PhD

Columbia University Medical Center
New York, NY United States
  Connect »